Bioherent

Startup
  • Location

    Hall 8.1 - 4YFN Stand 8.1D41.1

Information

Bioherent is a pioneering deep-tech company transforming in-vitro diagnostics through advanced photonic biosensing. Built on silicon photonics, microfluidics, and nanomaterials, Bioherent has developed its proprietary BioXplorer™ technology, an instrument designed for decentralized diagnostics and personalized medicine. Designed for versatility, BioXplorer™ can be rapidly adapted to multiple biomarkers and a wide range of clinical applications. Bioherent delivers rapid, reliable, and cost-effective results, enabling safer therapies and improved patient outcomes. Combined with the single-test disposable AllerWAVE®, it addresses drug allergy testing, a clinical area where current solutions are slow, risky, costly, and imprecise.

Key Information

  • Growth Stage
    Series A
  • Country
    Spain
  • Founding Year
    2021